These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 1488868

  • 1. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M.
    Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract] [Full Text] [Related]

  • 2. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI, Vardiman JW.
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [Abstract] [Full Text] [Related]

  • 3. Analysis of megakaryocyte ploidy in patients with thrombocytosis.
    Kanz L, Hollen C, Friese P, Burstein SA.
    Int J Cell Cloning; 1990 Jul; 8(4):299-306. PubMed ID: 2401806
    [Abstract] [Full Text] [Related]

  • 4. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP, Sanchez SR, Ewton AA, Rice L, Perkins SL, Dunphy CH, Chang CC.
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [Abstract] [Full Text] [Related]

  • 5. [Chronic myeloproliferative diseases].
    Verh Dtsch Ges Pathol; 1983 Oct; 67():214-75. PubMed ID: 6666266
    [No Abstract] [Full Text] [Related]

  • 6. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I, Galatâr N.
    Morphol Embryol (Bucur); 1989 Oct; 35(2):117-27. PubMed ID: 2529429
    [Abstract] [Full Text] [Related]

  • 7. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A.
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [Abstract] [Full Text] [Related]

  • 8. Increased fibroblast colony stimulating activity (F-CSA) in serum of myeloproliferative disorders.
    Han ZC, Briere J, Parent D, Abgrall JF, Sensebe L.
    J Biol Regul Homeost Agents; 1988 Jan; 2(3):119-24. PubMed ID: 3267102
    [Abstract] [Full Text] [Related]

  • 9. [Clinico-hematological characteristics of acute transformation of chronic myeloproliferative syndromes].
    Hernández JM, San Miguel JF, González M, Moraleda JM, Moro MJ, Hernández J, Cuesta B, López Borrasca A.
    Med Clin (Barc); 1991 Sep 28; 97(10):369-72. PubMed ID: 1745085
    [Abstract] [Full Text] [Related]

  • 10. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
    Wehmeier A, Südhoff T, Meierkord F.
    Semin Thromb Hemost; 1997 Sep 28; 23(4):391-402. PubMed ID: 9263357
    [Abstract] [Full Text] [Related]

  • 11. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R, Marzetta K, Miglioranza A, Redaelli S, Maino C, Maffiolini A, Gorini M.
    Recenti Prog Med; 2003 Sep 28; 94(7-8):314-20. PubMed ID: 12868237
    [Abstract] [Full Text] [Related]

  • 12. [Use of interferon in the treatment of chronic myeloproliferative disorders].
    Robak T.
    Acta Haematol Pol; 1992 Sep 28; 23(2 Suppl 1):30-7. PubMed ID: 1488870
    [Abstract] [Full Text] [Related]

  • 13. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
    Bartl R, Frisch B, Wilmanns W.
    Eur J Haematol; 1993 Jan 28; 50(1):41-52. PubMed ID: 8436214
    [Abstract] [Full Text] [Related]

  • 14. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J, Kvasnicka HM, Beelen DW, Flucke U, Spoer C, Paperno S, Leder LD, Schaefer UW.
    Mod Pathol; 2001 Feb 28; 14(2):129-38. PubMed ID: 11235904
    [Abstract] [Full Text] [Related]

  • 15. Density distribution and size of megakaryocytes in inflammatory reactions of the bone marrow (myelitis) and chronic myeloproliferative diseases.
    Thiele J, Holgado S, Choritz H, Georgii A.
    Scand J Haematol; 1983 Oct 28; 31(4):329-41. PubMed ID: 6578591
    [Abstract] [Full Text] [Related]

  • 16. Classification of chronic myeloproliferative diseases by bone marrow biopsies. Hematological and cytogenetic findings and clinical course.
    Georgii A, Vykoupil KF, Thiele J.
    Bibl Haematol; 1984 Oct 28; (50):41-56. PubMed ID: 6590038
    [No Abstract] [Full Text] [Related]

  • 17. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
    Thiele J, Funke S, Holgado S, Choritz H, Georgii A.
    Anal Quant Cytol; 1984 Sep 28; 6(3):155-67. PubMed ID: 6594964
    [Abstract] [Full Text] [Related]

  • 18. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
    Zankovich R, Thiele J, Fischer R, Diehl V.
    Med Klin (Munich); 1986 Jan 17; 81(1):31-5. PubMed ID: 3785010
    [No Abstract] [Full Text] [Related]

  • 19. Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia.
    Hyun BH, Gulati GL, Ashton JK.
    Clin Lab Med; 1990 Dec 17; 10(4):825-38. PubMed ID: 2272176
    [Abstract] [Full Text] [Related]

  • 20. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
    Greenberg PL.
    Clin Haematol; 1986 Nov 17; 15(4):973-93. PubMed ID: 3552351
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.